Search

Your search keyword '"GUITART, JOAN"' showing total 743 results
Start Over Author "GUITART, JOAN" Language english
743 results on '"GUITART, JOAN"'

2. Approach to Mycosis Fungoides in children: Consensus-based recommendations

Author

Zvulunov, Alex, Neale, Holly, Stern, Jonah, Santaguida, Pasqualina, Stein, Amy Buros, Koh, Mark, Eichenfield, Lawrence F., Guitart, Joan, Goebeler, Matthias, Scarisbrick, Julia, Willemze, Rein, Coughlin, Carrie C., George, Renu, Brazzelli, Valeria, Marschalkó, Márta, Belousova, Irena, Querfeld, Christiane, Bagot, Martine, Szepietowski, Jacek C., Papadavid, Evangelina, Quaglino, Pietro, Hoeger, Peter, Ortiz-Romero, Pablo L., Nikolaou, Vasiliki, Dummer, Reinhard, Aung, Phyu P., Lawley, Leslie, Morel, Kimberly D., Ngan, Bo, Wain, Mary, Gameiro, Ana, Lacy-Niebla, Rosa María, and Pope, Elena

Published
2024
Full Text
View/download PDF

4. ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

Author

Goyal, Amrita, O'Leary, Daniel, Dabaja, Bouthaina, Weng, Wen-Kai, Zain, Jasmine, Cutler, Corey, Guitart, Joan, Kim, Youn H., Geskin, Larisa J., Hoppe, Richard T., Wilson, Lynn D., Beaven, Anne W., Horwitz, Steve, Allen, Pamela B., Barta, Stefan K., Bohjanen, Kimberly, Brammer, Jonathan E., Carter, Joi B., Comfere, Nneka, DeSimone, Jennifer A., Dusenbery, Kathryn, Duvic, Madeleine, Huen, Auris, Jagadeesh, Deepa, Kelsey, Chris R., Khodadoust, Michael S., Lechowicz, Mary Jo, Mehta-Shah, Neha, Moskowitz, Alison J., Olsen, Elise A., Poh, Christina, Pro, Barbara, Querfeld, Christiane, Sauter, Craig, Sokol, Lubomir, Sokumbi, Olayemi, Wilcox, Ryan A., Zic, John A., Hamadani, Mehdi, and Foss, Francine

Published
2024
Full Text
View/download PDF

7. PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma

Author

Wartewig, Tim, Daniels, Jay, Schulz, Miriam, Hameister, Erik, Joshi, Abhinav, Park, Joonhee, Morrish, Emma, Venkatasubramani, Anuroop V., Cernilogar, Filippo M., van Heijster, Frits H. A., Hundshammer, Christian, Schneider, Heike, Konstantinidis, Filippos, Gabler, Judith V., Klement, Christine, Kurniawan, Henry, Law, Calvin, Lee, Yujin, Choi, Sara, Guitart, Joan, Forne, Ignasi, Giustinani, Jérôme, Müschen, Markus, Jain, Salvia, Weinstock, David M., Rad, Roland, Ortonne, Nicolas, Schilling, Franz, Schotta, Gunnar, Imhof, Axel, Brenner, Dirk, Choi, Jaehyuk, and Ruland, Jürgen

Published
2023
Full Text
View/download PDF

8. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., de Oliveira Araujo, Iguaracyra Barreto, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Di Napoli, Arianna, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr, Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Suzuki, Ritsuro, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2023
Full Text
View/download PDF

9. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis

Author

Mark, Erica, Kempf, Werner, Guitart, Joan, Pulitzer, Melissa, Mitteldorf, Christina, Hristov, Alexandra, Torres-Cabala, Carlos, Marchi, Enrica, Cropley, Thomas, Rodriguez Pinilla, Socorro Maria, Griffin, Teresa, Fernandez, Rony, Pileri, Stefano, Pileri, Alessandro, Tabanelli, Valentina, Borretta, Lisa, Subtil, Antonio, Plaza, Jose Antonio, Piris, Jose A. Miguel Angel, Feldman, Andrew L., Cerroni, Lorenzo, and Gru, Alejandro A.

Published
2024
Full Text
View/download PDF

16. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., Araujo, Iguaracyra Barreto de Oliveira, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr., Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2022
Full Text
View/download PDF

18. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Author

Olsen, Elise A., Whittaker, Sean, Willemze, Rein, Pinter-Brown, Lauren, Foss, Francine, Geskin, Larisa, Schwartz, Lawrence, Horwitz, Steven, Guitart, Joan, Zic, John, Kim, Youn H., Wood, Gary S., Duvic, Madeleine, Ai, Wei, Girardi, Michael, Gru, Alejandro, Guenova, Emmanuella, Hodak, Emmilia, Hoppe, Richard, Kempf, Werner, Kim, Ellen, Lechowicz, Mary Jo, Ortiz-Romero, Pablo, Papadavid, Evangelia, Quaglino, Pietro, Pittelkow, Mark, Prince, H. Miles, Sanches, Jose Antonio, Sugaya, Makoto, Vermeer, Maarten, Zain, Jasmine, Knobler, Robert, Stadler, Rudolf, Bagot, Martine, and Scarisbrick, Julia

Published
2022
Full Text
View/download PDF

19. Ionizing radiation improves skin bacterial dysbiosis in cutaneous T-cell lymphoma.

Author

Chrisman, Lauren P., Pang, Yanzhen, Hooper, Madeline J., Rajeev-Kumar, Greeshma, Nguyen, William Q., Green, Stefan J., Seed, Patrick C., Liang, Hua, Mittal, Bharat B., Hasan, Yasmin, Guitart, Joan, Weichselbaum, Ralph R., Burns, Michael B., and Zhou, Xiaolong A.

Abstract

Introduction: Cutaneous T-cell lymphoma (CTCL) is closely associated with the host microbiome. While recent evidence suggests that shifts in specific bacterial taxa are associated with response to UV-B, a form of non-ionizing radiation, the impact of ionizing radiation (IR) has not been investigated. Methods: 16S rRNA and tuf gene amplicon sequencing were performed on DNA extracted from swabs of lesional/non-lesional skin of 12 CTCL patients before/after TSEBT or local IR and from 25 matched healthy controls (HC). Microbial diversity and taxonomic profiles were analyzed. Results: Radiation exposure increased CTCL skin α-diversity to levels approximating HC. TSEBT appeared to carry the greatest effect compared to local IR. Both α and β-diversity differed significantly post versus pre-IR for TSEBT, but not for local IR. IR was associated with decreases in known pathogenic bacteria such as Streptococcus and S. aureus and increases in healthy commensal bacteria such as Anaerococcus, Bifidobacterium and commensal staphylococci including S. pettenkoferi. Substantially more taxa shifts were seen with TSEBT versus local IR. Discussion: IR not only eliminates CTCL lesions via induction of apoptosis, but also facilitates skin barrier restoration and recolonization of bacterial taxa associated with a healthy skin microbiome. Local IR does not have as strong an effect on the skin microbiome as TSEBT. As skin microbiota act as immunomodulators with local and potentially systemic influence, TSEBT may also improve CTCL lesions via global effects on the skin microbiome. Future larger-scale studies are required to fully elucidate the relationship between cutaneous microbes and IR treatment in CTCL. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

20. Development and psychometric properties of the Functional Assessment of Cancer Therapy–Cutaneous T-Cell Lymphoma (FACT-CTCL) instrument.

Author

Raymundo, Caroline, Cella, David, Wagner, Lynne I, Hippe, Daniel S, Di, Mengyang, Guitart, Joan, Rosen, Steven T, Querfeld, Christiane, and Shinohara, Michi M

Subjects
EXPLORATORY factor analysis, INTRACLASS correlation, MYCOSIS fungoides, ELECTRONIC health records, T-cell lymphoma
Abstract

Background Patients with mycosis fungoides (MF)/Sézary Syndrome (SS) can experience impacted health-related quality of life (HRQoL). Objectives To validate the CTCL-S, a novel subscale of the Functional Assessment of Cancer Therapy–General (FACT-G), in patients with MF/SS. Methods Qualitative interviews were conducted with expert clinicians and patients with MF/SS. Thematic analysis identified the most common concerns, and 19 items were selected. Patients with MF/SS were recruited from a single centre. FACT-G, CTCL-S (collectively 'FACT-CTCL'), Skindex-29 and Visual Analogue Scale–Pruritis (VAS-itch) were administered. A subset repeated FACT-CTCL and VAS-itch after ≈2 weeks. Patient demographics and clinical characteristics were obtained via review of the electronic medical records. Psychometric properties were assessed. Internal consistency was estimated using Cronbach's α. Convergent and discriminant validity were assessed by comparing CTCL-S with disease stage, age, VAS-itch, FACT-G and Skindex-29. Exploratory factor analysis (EFA) was used to preliminarily assess CTCL-S dimensionality. Test–retest repeatability was summarized using intraclass correlation coefficient (ICC), within-subject standard deviation and within-subject coefficient of variation. Results Seventy-two patients completed the initial survey, and 35 repeated the FACT-CTCL and VAS-itch after ≈2 weeks. Two-thirds were men; most were White (78%). The majority (85%) had MF, 15% had SS and 75% early (stage IA–IIA) and 25% advanced (≥ stage IIB) disease. Preliminary EFA found a single predominant factor, supporting a hypothesis of unidimensionality of the CTCL-S. Internal consistency of the CTCL-S was high, with α = 0.95 [95% confidence interval (CI) 0.93–0.96]. There was no significant change in CTCL-S average test–retest scores [ICC 0.93 (P = 0.63)]. CTCL-S was significantly lower in advanced vs. early-stage disease [median (interquartile range) 34 (26–48) vs. 59 (44–68), P < 0.001] and strongly correlated with VAS-itch [Spearman's r (rs) –0.70, 95% CI –0.81 to –0.55], FACT-G (rs 0.77, 95% CI 0.65–0.85) and Skindex-29 (rs –0.90, 95% CI –0.94 to –0.84), supporting convergent validity. CTCL-S scores had little correlation with age (rs 0.19, 95% CI –0.05 to 0.41, P = 0.12), supporting discriminant validity. Conclusions The FACT-CTCL is a disease-specific instrument for assessing HRQoL with high reproducibility and good performance in a cohort of patients with MF/SS. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

22. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

Author

Park, Joonhee, Daniels, Jay, Wartewig, Tim, Ringbloom, Kimberly G., Martinez-Escala, Maria Estela, Choi, Sara, Thomas, Jane J., Doukas, Peter G., Yang, Jingyi, Snowden, Caroline, Law, Calvin, Lee, Yujin, Lee, Katie, Zhang, Yancong, Conran, Carly, Tegtmeyer, Kyle, Mo, Samuel H., Pease, David R., Jothishankar, Balaji, Kwok, Pui-Yan, Abdulla, Farah R., Pro, Barbara, Louissaint, Abner, Boggon, Titus J., Sosman, Jeffrey, Guitart, Joan, Rao, Deepak, Ruland, Jürgen, and Choi, Jaehyuk

Published
2021
Full Text
View/download PDF

23. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features

Author

Zhou, Xiaolong Alan, Yang, Jingyi, Ringbloom, Kimberly G., Martinez-Escala, Maria Estela, Stevenson, Kristen E., Wenzel, Alexander T., Fantini, Damiano, Martin, Haley K., Moy, Andrea P., Morgan, Elizabeth A., Harkins, Shannon, Paxton, Christian N., Hong, Bo, Andersen, Erica F., Guitart, Joan, Weinstock, David M., Cerroni, Lorenzo, Choi, Jaehyuk, and Louissaint, Abner, Jr

Published
2021
Full Text
View/download PDF

25. Interstitial mycosis fungoides: A rare presentation of mycosis fungoides with overlapping granulomatous and folliculotropic features.

Author

Chung, Christopher, Wu, Bicong, LeWitt, Tessa, Griffin, Teresa, Hooper, Madeline, Zhou, Xiaolong, Choi, Jaehyuk, and Guitart, Joan

Subjects
MYCOSIS fungoides, T-cell receptor genes, MULTINUCLEATED giant cells, GENE rearrangement, DISEASE remission
Abstract

Background: Interstitial mycosis fungoides (IMF) is a rare subtype of mycosis fungoides (MF) characterized by atypical lymphocytes infiltrating the reticular dermis between collagen bundles with limited epidermotropism and variable granulomatous features. Methods: Retrospective single institution review of 31 cases of IMF including clinical characteristics, disease course and pathological features. Results: Our cohort was predominately male (19; 61%, M:F 1.6:1) with a mean age at diagnosis of 43 years (range 11–85), mean signs/symptoms duration of 7 years prior to diagnosis, and 6 years mean follow‐up duration. Clinically, patients often exhibited symmetric ill‐defined patches/plaques involving intertriginous regions with tan‐yellow hyperpigmentation and follicular‐based papules, wrinkling, and alopecia. Lymphadenopathy was noted in seven patients. Fifteen (52%) patients were in near or complete clinical remission at the latest follow‐up. T‐cell receptor gene rearrangement was positive in 23/24 (96%) cases. Histopathologically, atypical cells were small–medium, CD4+ (29; 94%) or rarely CD4+/CD8+ (1; 3%) lymphocytes infiltrating the reticular dermis with thickened collagen bundles (27; 87%), multinucleated giant cells (12; 39%), and often tracing along adnexa with subtle folliculotropism (12/20; 60%). Conclusions: Our study demonstrates IMF is an indolent subtype of MF with distinct features, including frequent granulomatous and subtle follicular involvement resulting in alopecia. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

Author

Guitart, Joan, Martinez-Escala, M Estela, Subtil, Antonio, Duvic, Madeleine, Pulitzer, Melissa P, Olsen, Elise A, Kim, Ellen, Rook, Alain H, Samimi, Sara S, Wood, Gary S, Girardi, Michael, Junkins-Hopkins, Jacqueline, Ivan, Doina S, Selim, M Angelica, Sable, Kimberly A, Virmani, Pooja, Pincus, Laura B, Tetzlaff, Michael T, Kim, Jinah, and Kim, Youn H

Published
2017
Full Text
View/download PDF

36. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas

Author

Daniels, Jay, Doukas, Peter G., Escala, Maria E. Martinez, Ringbloom, Kimberly G., Shih, David J. H., Yang, Jingyi, Tegtmeyer, Kyle, Park, Joonhee, Thomas, Jane J., Selli, Mehmet E., Altunbulakli, Can, Gowthaman, Ragul, Mo, Samuel H., Jothishankar, Balaji, Pease, David R., Pro, Barbara, Abdulla, Farah R., Shea, Christopher, Sahni, Nidhi, Gru, Alejandro A., Pierce, Brian G., Louissaint, Jr, Abner, Guitart, Joan, and Choi, Jaehyuk

Published
2020
Full Text
View/download PDF

45. Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.

Author

Nguyen, William Q., Chrisman, Lauren P., Enriquez, Gail L., Hooper, Madeline J., Griffin, Teresa L., Ahmad, Merjaan, Rahman, Sophia, Green, Stefan J., Seed, Patrick C., Guitart, Joan, Burns, Michael B., and Zhou, Xiaolong A.

Subjects
CUTANEOUS T-cell lymphoma, THERAPEUTICS, FECAL microbiota transplantation, GUT microbiome, ATOPIC dermatitis
Abstract

Recent studies have shown a close relationship between cutaneous T-cell lymphoma (CTCL) and its microbiome. CTCL disease progression is associated with gut dysbiosis and alterations in bacterial taxa parallel those observed in immunologically similar atopic dermatitis. Moreover, the microbial profile of lesional skin may predict response to narrowband ultraviolet B (nbUVB), a common skin-directed therapy. However, the relationship between the gut microbiome, an immunologically vital niche, and nbUVB remains unexplored in CTCL. Herein, we performed 16S rRNA sequencing and PICRUSt2 predictive metagenomics on DNA extracted from stool swabs of 13 CTCL patients treated with nbUVB, 8 non-treated patients, and 13 healthy controls. Disease response was assessed with modified Severity Weighted Assessment Tool (mSWAT); of nbUVB-treated patients, 6 improved (decreased mSWAT), 2 remained stable, and 5 worsened (increased mSWAT). Protective commensal bacteria including Lactobacillaceae and Erysipelatoclostridiaceae were significantly less abundant in CTCL patients compared to controls. With treatment, the CTCL gut microbiome exhibited decreased phylogenetic diversity and lower relative abundance of pro-inflammatory Sutterellaceae. Sutterellaceae was also significantly more abundant in patients who worsened, and Eggerthellaceae and Erysipelotrichaceae trended higher in patients who improved. Finally, PICRUSt2 functional predictions based on shifts in abundance of bacterial sequences repeatedly identified alterations in inositol degradation, which plays a key role in host immunomodulation, including inositol phospholipid signaling relevant to T-cell survival and proliferation. Our results bolster the paradigm of gut dysbiosis in CTCL and its functional implications in disease pathogenesis, and further delineate bacterial taxa associated with nbUVB response and with nbUVB treatment itself. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

46. Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel.

Author

Quaglino, Pietro, Pimpinelli, Nicola, Zinzani, Pier Luigi, Paulli, Marco, Pileri, Stefano, Berti, Emilio, Cerroni, Lorenzo, Guitart, Joan, Kim, Youn H., Rupoli, Serena, Santucci, Marco, Simontacchi, Gabriele, Vermeer, Maarten, Hoppe, Richard, Pro, Barbara, Swerdlow, Steven H., and Barosi, Giovanni

Subjects
LYMPHOMAS, LYMPHOPROLIFERATIVE disorders, SCIENTIFIC literature, CUTANEOUS T-cell lymphoma, GENERAL practitioners, HEMATOLOGISTS
Abstract

Primary cutaneous B‐cell lymphomas (PCBCLs) are lymphoproliferative disorders that appear on the skin without evidence of extracutaneous manifestations at the time of diagnosis. There is a lack of evidence‐based guidelines for their clinical management due to the availability of very few large scale studies and controlled clinical trials. Here we present and discuss a series of major unmet clinical needs (UCNs) in the management of PCBCLs by a panel of 16 experts involved in research and clinical practice of PCBCL. The Panel produced recommendations on the appropriateness of the clinical decisions concerning the identified clinical needs and proposed research for improving the knowledge needed to solve them. Recommendations and proposals were achieved by multiple‐step formalized procedures to reach a consensus after a comprehensive analysis of the scientific literature. Recommendations and proposals lay in the domain of classification uncertainties of PCBCL, optimization of diagnosis, optimization of prognosis, optimization of staging and critical issues on therapeutic strategies with particular focus on new treatments. These recommendations are intended for use not only by experts but above all by dermatologists and hematologists with limited experience in the field of PCBCLs as well as general practitioners. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

50. O-134 - Elucidating genetic factors of cutaneous T-cell lymphoma staging and disease severity through machine learning

Author

Schreidah, Celine M., Reynolds, George Bingham, Shen, Haoyang, Fahmy, Lauren M., Choi, Jaehyuk, Duvic, Madeleine, Gallardo, Fernando, Girardi, Michael, Guitart, Joan, Kim, Youn H., Khodadoust, Michael, Najidh, Safa, Ni, Xiao, Pujol, Ramon M., Tensen, Cornelis P., Vermeer, Maarten H., Whittaker, Sean, Tatonetti, Nicholas P., Chase, Herbert S., Pe’er, Itsik, and Geskin, Larisa J.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results